Prognostic factor disease free survival. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Lymph Nodes Cell Line, Tumor Bone Marrow Neoplastic Cells, Circulating Bile Ducts, Intrahepatic Lymphocytes, Tumor-Infiltrating

Diseases80

Neoplasm Recurrence, Local Breast Neoplasms Lymphatic Metastasis Neoplasm Invasiveness Carcinoma, Squamous Cell Adenocarcinoma Colorectal Neoplasms Recurrence Carcinoma Liver Neoplasms Carcinoma, Ductal, Breast Neoplasm Metastasis Lung Neoplasms Disease Progression Carcinoma, Non-Small-Cell Lung Bone Neoplasms Ovarian Neoplasms Stomach Neoplasms Sarcoma Hodgkin Disease Brain Neoplasms Carcinoma, Hepatocellular Lymphoma, Non-Hodgkin Neoplasm, Residual Melanoma Head and Neck Neoplasms Kidney Neoplasms Pancreatic Neoplasms Rectal Neoplasms Carcinoma, Renal Cell Skin Neoplasms Osteosarcoma Adenocarcinoma, Mucinous Multiple Myeloma Soft Tissue Neoplasms Neoplasms, Germ Cell and Embryonal Nasopharyngeal Neoplasms Uterine Cervical Neoplasms Prostatic Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Neoplasms, Glandular and Epithelial Urinary Bladder Neoplasms Endometrial Neoplasms Esophageal Neoplasms Gastrointestinal Neoplasms Mediastinal Neoplasms Testicular Neoplasms Glioblastoma Lymphoma, Large B-Cell, Diffuse Leukemia, Myeloid, Acute Bile Duct Neoplasms Cholangiocarcinoma Acute Disease Colonic Neoplasms Leukemia, Lymphocytic, Chronic, B-Cell Supratentorial Neoplasms Neoplastic Cells, Circulating Postoperative Complications Chromosome Aberrations Glioma Pleural Neoplasms Leukemia, Myeloid Neoplasms Astrocytoma Neovascularization, Pathologic Carcinoma, Transitional Cell Carcinoma, Small Cell Myelodysplastic Syndromes Mesothelioma Laryngeal Neoplasms Oligodendroglioma Cystadenocarcinoma, Serous Neuroblastoma Lymphoma, Follicular Peritoneal Neoplasms Lymphoma, B-Cell Carcinoma, Papillary Mouth Neoplasms Myocardial Infarction Retroperitoneal Neoplasms

Chemicals and Drugs55

Tumor Markers, Biological Cyclophosphamide Fluorouracil Receptors, Estrogen Receptor, erbB-2 Vincristine Antineoplastic Agents Cisplatin Doxorubicin Receptors, Progesterone Ki-67 Antigen Prednisone Etoposide Neoplasm Proteins Methotrexate Carboplatin Tumor Suppressor Protein p53 Antineoplastic Agents, Hormonal Bleomycin Tamoxifen Antibodies, Monoclonal Paclitaxel Free Radicals RNA, Messenger Antigens, Neoplasm Cytarabine Biological Markers Antimetabolites, Antineoplastic Leucovorin Organoplatinum Compounds L-Lactate Dehydrogenase Deoxycytidine Antineoplastic Agents, Alkylating Antibodies, Monoclonal, Murine-Derived Ifosfamide Antibodies, Monoclonal, Humanized Receptor, Epidermal Growth Factor DNA, Neoplasm Taxoids alpha-Fetoproteins Carcinoembryonic Antigen Procarbazine Vinblastine Antineoplastic Agents, Phytogenic Proto-Oncogene Proteins Melphalan Mechlorethamine Prostate-Specific Antigen Dacarbazine CA-19-9 Antigen Protein Kinase Inhibitors Vindesine Lomustine Vascular Endothelial Growth Factor A Tumor Suppressor Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment90

Disease-Free Survival Prognosis Survival Rate Neoplasm Staging Survival Analysis Retrospective Studies Treatment Outcome Kaplan-Meier Estimate Combined Modality Therapy Follow-Up Studies Antineoplastic Combined Chemotherapy Protocols Proportional Hazards Models Multivariate Analysis Immunohistochemistry Chemotherapy, Adjuvant Radiotherapy, Adjuvant Predictive Value of Tests Radiotherapy Dosage Prospective Studies Risk Factors Immunoenzyme Techniques Neoplasm Grading Cohort Studies Remission Induction Risk Assessment Lymph Node Excision Neoadjuvant Therapy Tissue Array Analysis Actuarial Analysis Salvage Therapy Radiotherapy Drug Administration Schedule Chemoradiotherapy Transplantation, Autologous Hematopoietic Stem Cell Transplantation Reverse Transcriptase Polymerase Chain Reaction Tumor Burden Chi-Square Distribution Analysis of Variance Hepatectomy Brachytherapy Mitotic Index Gene Expression Profiling Transplantation, Homologous Karnofsky Performance Status Dose Fractionation Clinical Trials as Topic Registries Mastectomy Randomized Controlled Trials as Topic Tomography, X-Ray Computed Severity of Illness Index Gastrectomy Life Tables Case-Control Studies Bone Marrow Transplantation ROC Curve Radiotherapy, Conformal Prostatectomy Sensitivity and Specificity Probability Treatment Failure Reproducibility of Results Radiotherapy, Intensity-Modulated Regression Analysis In Situ Hybridization, Fluorescence Multicenter Studies as Topic Karyotyping Logistic Models Cause of Death Incidence Pneumonectomy Cytogenetic Analysis Risk Oligonucleotide Array Sequence Analysis Leukocyte Count Peripheral Blood Stem Cell Transplantation Nomograms Clinical Trials, Phase III as Topic Biopsy Patient Selection Polymerase Chain Reaction Metastasectomy Esophagectomy Statistics, Nonparametric Blotting, Western Preoperative Care Biopsy, Needle Clinical Trials, Phase II as Topic Positron-Emission Tomography

Phenomena and Processes21

Time Factors Cell Survival Gene Expression Regulation, Neoplastic Graft Survival Chi-Square Distribution Mutation Ploidies Cell Proliferation Drug Resistance, Neoplasm Apoptosis Sensitivity and Specificity Probability Chromosome Aberrations Dose-Response Relationship, Drug Signal Transduction Risk Leukocyte Count Nomograms Gene Amplification Gene Expression Genes, p53

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

Information Science7

Survival Rate Registries Life Tables Radiotherapy, Conformal Radiotherapy, Intensity-Modulated Cause of Death Incidence

Named Groups1

Infant, Newborn

Health Care43

Disease-Free Survival Survival Rate Survival Analysis Retrospective Studies Treatment Outcome Kaplan-Meier Estimate Follow-Up Studies Proportional Hazards Models Multivariate Analysis Predictive Value of Tests Prospective Studies Risk Factors Cohort Studies Age Factors Risk Assessment Actuarial Analysis Chi-Square Distribution Analysis of Variance Karnofsky Performance Status Clinical Trials as Topic Registries Randomized Controlled Trials as Topic Severity of Illness Index Life Tables Case-Control Studies ROC Curve Sensitivity and Specificity Sex Factors Probability Treatment Failure Reproducibility of Results Regression Analysis Multicenter Studies as Topic Logistic Models Cause of Death Incidence Risk Nomograms Clinical Trials, Phase III as Topic Patient Selection Statistics, Nonparametric Preoperative Care Clinical Trials, Phase II as Topic

Geographicals3

Japan France Egypt

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Health Care

Disease-Free Survival Prognosis Survival Rate Neoplasm Staging Survival Analysis Retrospective Studies Treatment Outcome Neoplasm Recurrence, Local Kaplan-Meier Estimate Breast Neoplasms Combined Modality Therapy Tumor Markers, Biological Follow-Up Studies Lymphatic Metastasis Antineoplastic Combined Chemotherapy Protocols Proportional Hazards Models Multivariate Analysis Immunohistochemistry Chemotherapy, Adjuvant Radiotherapy, Adjuvant Time Factors Predictive Value of Tests Neoplasm Invasiveness Carcinoma, Squamous Cell Adenocarcinoma Radiotherapy Dosage Prospective Studies Colorectal Neoplasms Cell Survival Cyclophosphamide Fluorouracil Recurrence Carcinoma Liver Neoplasms Carcinoma, Ductal, Breast Risk Factors Receptors, Estrogen Immunoenzyme Techniques Receptor, erbB-2 Neoplasm Metastasis Lung Neoplasms Gene Expression Regulation, Neoplastic Survival Disease Progression Vincristine Neoplasm Grading Antineoplastic Agents Cohort Studies Cisplatin Remission Induction Age Factors Carcinoma, Non-Small-Cell Lung Doxorubicin Bone Neoplasms Ovarian Neoplasms Receptors, Progesterone Lymph Nodes Stomach Neoplasms Ki-67 Antigen Prednisone Sarcoma Risk Assessment Lymph Node Excision Neoadjuvant Therapy Hodgkin Disease Etoposide Brain Neoplasms Neoplasm Proteins Tissue Array Analysis Carcinoma, Hepatocellular Actuarial Analysis Salvage Therapy Graft Survival Lymphoma, Non-Hodgkin Methotrexate Radiotherapy Neoplasm, Residual Melanoma Head and Neck Neoplasms Drug Administration Schedule Chemoradiotherapy Kidney Neoplasms Pancreatic Neoplasms Rectal Neoplasms Transplantation, Autologous Carcinoma, Renal Cell Skin Neoplasms Osteosarcoma Hematopoietic Stem Cell Transplantation Reverse Transcriptase Polymerase Chain Reaction Tumor Burden Adenocarcinoma, Mucinous Carboplatin Tumor Suppressor Protein p53 Chi-Square Distribution Multiple Myeloma Cell Line, Tumor Analysis of Variance Soft Tissue Neoplasms Hepatectomy

No FAQ available that match "prognostic factor disease free survival"